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Title: Designing a robust and portable workflow for detecting genetic variants associated with 
molecular phenotypes across multiple studies 
Abstract: 
Quantitative trait locus (QTL) analysis links variations in molecular phenotype expression levels 
to genotype variation. This analysis has become a standard practice to better understand molecular 
mechanisms underlying complex traits and diseases. Typical QTL analysis consists of multiple 
steps. Although a diverse set of tools is available to perform these individual analysis, the tools 
have so far not been integrated into a reproducible and scalable workflow that is easy to use across 
a wide range computational environments. Our analysis workflow consists of three modules. The 
analysis starts with quantification of the phenotype of interest, proceeds with normalisation and 
quality control and finishes with the QTL analysis. For phenotype quantification and QTL 
mapping modules we developed pipelines following best practices of the nf-core framework. The 
pipelines are containerized, open-source, extensible and eligible to be parallelly executed in a 
variety computational environments. For quality control module we developed a script which 
automatically computes the measures of quality and provides user with information. As a proof of 
concept, we uniformly processed more than 40 context specific groups from more than 15 studies 
and discovered at least one significant eQTL for more than 9000 genes. We believe that adopting 
our pipelines will increase reproducibility, portability and robustness of QTL analysis in 
comparison to existing approaches.  
Keywords: pipeline; workflow; bioinformatics tools; workflow framework; QTL mapping; 
containerized pipeline 
CERCS: B110 Bioinformatics, medical informatics, biomathematics, biometrics 
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Pealkiri eesti keeles Töökindla ja teisaldatava töövoo väljatöötamine molekulaarsete tunnustega 
seotud geneetiliste variantide tuvastamiseks mitmetest andmestikest 
Lühikokkuvõte: 
Kvantitatiivse tunnuse lookusteks (quantitative trait locus, QTL) nimetatakse geneetilisi variante, 
millel on statistiline seos mõne molekulaarse tunnusega. QTL analüüs võimaldab paremini aru 
saada komplekshaiguseid ja tunnuseid mõjutavatest molekulaarsetest mehhanismidest. Tüüpiline 
QTL analüüs koosneb suurest hulgast sammudest, mille kõigi jaoks on olemas palju erinevaid 
tööriistu, kuid mida ei ole siiani kokku pandud ühte lihtsasti kasutatavasse, teisaldatavasse ning 
korratavasse töövoogu. Käesolevas töös loodud töövoog koosneb kolmest moodulist: huvipakkuva 
tunnuse kvantifitseerimine (i), andmete normaliseerimine ja kvaliteedikontroll (ii) ning QTL 
analüüs (iii). Kvantifitseerimise ja QTL analüüsi moodulite jaoks kasutasime Nextflow töövoo 
juhtimise süsteemi ning järgisime kõiki nf-core raamistiku parimaid praktikaid. Mõlemad töövoo 
moodulid on avatud lähekoodiga ning kasutavad tarkvarakonteinereid, mis võimaldab kasutajatel 
neid lihtsalt laiendada ning jooksutada erinevates arvutuskeskkondades. Kvaliteedikontrolli 
teostamiseks ning andmete normaliseerimiseks arendasime välja skripti, mis automaatselt arvutab 
välja erinevad kvaliteedimõõdikud ning esitab need kasutajale. Juhtprojekti raames viisime läbi 
geeniekspressiooni QTL analüüsi 15 andmestikus ja 40 erinevas bioloogilises kontekstis ning 
tuvastasime vähemalt ühe statistiliselt olulise QTLi enam kui 9000 geenile. Loodud töövoogude 
laialdasem kasutuselevõtt võimaldab muuta QTL analüüsi korratavamaks, teisaldatavamaks ning 
lihtsamini kasutatavaks. 
Võtmesõnad: töövoog, QTL analüüs, töövoo raamistik, konteinerdamine 
CERCS: B110 Bioinformaatika, meditsiiniinformaatika, biomatemaatika, biomeetrika 
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1. Introduction 
1.1. Terms and Notions 
Deoxyribonucleic acid (DNA): A molecule carrying genetic information and composed of four 
nucleotides (cytosine [C], guanine [G], adenine [A] or thymine [T]) 
Ribonucleic acid (RNA): A molecule primarily created on basis of DNA code and also composed 
of four nucleotides (cytosine [C], guanine [G], adenine [A] or uracil [U]). RNA has various 
biological roles in a cell. 
Nucleotide: organic molecules that serve as building units of DNA and RNA 
Genomic variant: a difference in a specific position between genotypes of two organisms 
belonging to the same species  
Single Nucleotide Polymorphism (SNP): genomic variant which occurs as a substitution of single 
nucleotide 
Gene: a sequence of nucleotides in DNA or RNA that codes for a molecule that has a function. 
Transcript: one of the possible versions of the gene sequence. 
Genomic feature: a genomic region with some annotated function. (e.g. gene, transcript, exon) 
Expression: Abundance of the specific genomic feature in a specified biological environment 
Sample: Genetic material obtained from a specific source (e.g. human, tissue) 
Phenotype: The set of observable characteristics of a sample (e.g. gene and exon expression levels) 
Genotype: The genetic constitution of an individual organism.  
Metadata: A set of data that describes and gives information about other data. 
Computation node: A set of configured hardware in order to serve computational power 
Computation cluster: A set of computation nodes 
Job (Task): A computational activity to be executed in computation node and requiring pre-defined 
amount of computational power.  
Executor (Job scheduling system): A software to orchestrate execution of tasks in the computation 
cluster. 
Execution environment: An environment equipped with necessary software in order to execute 
tasks. 
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1.2. Biological Background 
Bioinformatics is a multidisciplinary field which needs the expertise of biologists, software 
engineers and computer scientists (Brass, 2000). To make efficient tools for biologists, software 
engineers and computer scientists should understand the basics of the domain they are working in. 
Thus, knowledge of the central dogma of molecular biology, Genome Wide Association Studies, 
Quantitative Trait Loci mapping and colocalisation is essential. 
1.2.1. Central Dogma of Molecular Biology 
In molecular biology, molecular functions are mostly performed by proteins. These large and 
complex molecules are required for the structure, function and regulation of organism’s tissues. 
The abundance or structure of the specific protein in human cells can provide information about a 
specific trait (e.g. disease) (Dermitzakis, 2008; Emilsson et al., 2008; Liu, Gershon, & Kelsoe, 
2017). The idea of the central dogma describes the process of protein production from genetic 
code. This unidirectional process consists of two main steps: transcription and translation, and 
can be described as DNA ⇨  RNA ⇨  Protein (Figure 1.1). 
Figure 1.1. High level representation of central dogma of molecular biology. 
Figure obtained from molecular biology curriculum of KhanAcademy1. 
In the human body, all cells have the same DNA, however the amount of transcribed RNA is 
different. The amount of transcribed RNA from a specific gene determines the gene expression 
level, which directly affects protein abundance produced from the same gene. Although each cell 
can express (activate, turn on) majority of the genes, some cell types can additionally express 
specific genes and repress (unexpress, turn off) others (Ramsköld, Wang, Burge, & Sandberg, 
2009). The behaviour of expressing and repressing the genes is called gene regulation. Gene 
                                                 
1
https://www.khanacademy.org/science/biology/gene-expression-central-dogma/transcription-of-dna-into-
rna/a/overview-of-transcription 
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regulation plays an important role in cell development, functionality and adaptation to the 
environment. Genes are regulated in different patterns, for example, muscle cells have to look and 
function differently from a brain cell or liver cell. Although we know that gene regulation is vital 
for life, this complicated process is not fully understood yet2. Gene regulation most commonly 
occurs at the transcription level, however it can be effective in any step of gene expression. 
Transcription is the process of producing messenger RNA (mRNA) from DNA. One strand of 
the DNA double helix acts as a template for the construction of a matching complementary RNA 
strand. A molecular machine called the RNA polymerase binds to a promoter region of a gene with 
the help of transcription factors, and starts to copy a sequence of the gene to an RNA molecule. 
In eukaryotic cells (e.g. human cells), the transcribed RNA molecule in this stage is considered 
“immature” RNA (a.k.a. pre-mRNA or primary transcript), and needs to go through modifications 
(RNA processing) to become a mature mRNA. These modifications are splicing, capping and 
polyadenylation (poly-A tail addition), and are the main events which designate the content of 
mature mRNA.  
A pre-mRNA contains exons (regions in genes which will become a piece of mature mRNA) and 
introns (regions which do not survive the RNA processing modifications). In the splicing process, 
introns are removed and exons are joined in order to form mRNA from pre-mRNA. Splicing occurs 
in the nucleus of the cell, either during the transcription process or immediately after transcription 
is completed. Sometimes alternative splicing occurs, where splicing process creates different 
sequences of mRNA by varying the exon composition of pre-mRNA (J. Chen & Weiss, 2015; Y. 
Wang et al., 2015). When alternative splicing happens, different combinations of exon and intron 
usage result in production of a variety of proteins and other gene products (Figure 1.2). Alternative 
splicing is not a random process. It is regulated by regulatory protein molecules and often depends 
on genetic variants within or nearby the transcribed gene. 
Other two steps of pre-mRNA processing are five-prime capping (5’ capping) and three-prime (3’) 
end tail polyadenylation. The 5’ end of the transcribed gene is the side where the transcription 
starts and capping of this side happens shortly after the transcription is initiated. A special molecule 
is added to the 5’ end to make mRNA more stable and mature to be able to undergo the translation 
process. Polyadenylation (poly(A)) on the other hand, is the addition of multiple adenine bases to 
specific (poly(A)) site in the 3’ end of the newly transcribed pre-mRNA. This process is also vital 
for stability and translation of the mRNA, because the tail of the mRNA is shortened overtime and 
absence of poly(A) tail can result in degradation of the mRNA before reaching the translation. 
Usually, protein coding genes have multiple polyadenylation sites, so poly(A) tail can be added in 
any of them and change the content of mRNA. This phenomenon, called alternative 
polyadenylation, makes it possible to produce different mRNAs from one gene that are different 
in their 3’ ends, eventually ending up with production of different proteins. Alternative promoter 
                                                 
2
 https://ghr.nlm.nih.gov/primer/howgeneswork/geneonoff 
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usage (choice), on the other hand, is another regulatory event, which defines the first exon of a 
gene to be transcribed (Figure 1.2) (Ayoubi & Van De Ven, 1996; Kimura et al., 2006).  
Translation is the process where a mature mRNA is decoded in order to build a protein or a 
subunit of a protein. In eukaryotes (organisms whose cells have a nucleus), it happens outside of 
the nucleus by ribosomes with the help of transport RNA (tRNA). Although gene expression can 
also be regulated at the translation level (Wilkie, Dickson, & Gray, 2003), we will not discuss this 
further, because the RNA sequencing data used in this thesis measures mRNA abundance. 
1.2.2. Quantifying RNA-seq Transcription  
RNA sequencing (RNA-seq) data are essentially a collection of text strings representing nucleotide 
sequences. To produce this data, mature mRNA is extracted from the cell, fragmented, 
complementary DNA (cDNA) fragments made and then sequenced with a high-throughput 
sequencing machine (Marioni, Mason, Mane, Stephens, & Gilad, 2008) (Figure 1.3). High-
throughput sequencing machines produce short sequences of basepais, called sequencing reads. 
To extract interpretable information from the experiment, the reads need to be aligned to the 
reference sequence to quantify the relative counts of specific phenotypes. For instance, to quantify 
gene expression, the reads should be aligned to the reference genome sequence of the 
corresponding species (Figure 1.3). 
 
Figure 1.2. Symbolic representation of alternative splicing, 
alternative promoter and alternative polyadenylation events. 
Figure is obtained from (J. Chen & Weiss, 2015) study. 
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Figure 1.3. Visual summary of RNA-seq data sequencing and alignment. Figure obtained 
from RNA-seq wikipedia article3 and is available under CC BY 4.0 license4 
Reads produced by the sequencing machines are usually stored in the FASTQ file format (Figure 
1.4). 
1.2.3. Genetic variation 
The human genome is 3.1 billion nucleotides long and there are two copies of each chromosome. 
Any two individuals differ from each other at 0.5% of the loci, which means there are differences 
in more than 100 million locations (a.k.a. genetic variants). Each variant can have either reference 
                                                 
3
 https://en.wikipedia.org/wiki/RNA-Seq 
4
 Thomas Shafee [CC BY 4.0 (https://creativecommons.org/licenses/by/4.0)] 
 
 
 
Figure 1.4. Example of a read in FASTQ file. First line: unique identifier, second line: sequence of bases, third 
line: optional unique ID repetition with description, fourth line: quality values for sequence of bases in line 2. 
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or alternative allele inherited from one of the parents. Since humans have two sets of each 
chromosome (diploid, one inherited from the mother and another from the father), there are three 
possible value combinations of the inherited variant (1000 Genomes Project Consortium et al., 
2015). For instance, in Table 1.1 variant with ID chr1_1301656_T_C has a reference allele of 
nucleotide “T” and alternative allele of nucleotide “C” in the reference genome. Hence, three 
possible inheritance combinations are “TT”, “TC” and “CC” (“CT” is the equivalent of “TC”). 
The sample (e.g. donor, person) indicated with ID “geno_275” has two reference alleles (e.g. “TT”, 
homozygous) inherited from the parents, and does not inherit alternative allele for this variant. The 
same person has one copy of both reference and alternative alleles for the variant 
chr1_1302799_C_A (e.g. “CA”, heterozygous). Genotypes can be measured using genotyping 
microarrays or whole genome sequencing. Genotype data is typically stored in variant call format 
(VCF, (Danecek et al., 2011)) files (Table 1.1). 
1.2.4. Genome-Wide Association Studies (GWASs) 
The main goal of human genetics is to find genetic risk factors for the specific traits (e.g. diseases). 
There are a number of different tools, study designs and technologies to identify these risk factors. 
GWAS is an observational study of genetic variants in a specific cohort of individuals, which aims 
to find if any genetic variant is associated with a particular trait (e.g. disease). If a new genetic 
association is identified, researchers can contribute this finding to the pool of associations for 
future use by the community. This tremendous database helps researchers to come up with better 
strategies to detect, treat or prevent various diseases (Buniello et al., 2018). GWASs have been 
continuously grown over the past fifteen years into a great resource. While interpreting the 
complexity of human diseases is an essential objective, it is not the only target of human genetics. 
Pharmacology is a major beneficiary of GWAS. Pharmacogenetics studies associations of DNA 
sequence variations with drug metabolism and efficacy along with negative effects (Bush & 
Moore, 2012). This type of genetic studies have led to establishment of a new field called 
personalised medicine that aims to fit healthcare to individual patients based on their genetic 
information and other biological parameters. 
1.2.5. Quantitative Trait Locus (QTL) Mapping 
Another method for identifying associations between phenotypic data (traits) and genotypic data 
is quantitative trait locus (QTL) analysis. This statistical method attempts to clarify genetic bases 
of variation in complex traits. The phenotypic data in QTL analysis are quantitative traits which 
Table 1.1. Visual representation of two variants in VCF file format. 
CHR POS ID REF ALT QUAL FILTER INFO FORMAT geno_275 
1 1301656 chr1_1301656_T_C T C 100 PASS --- GT 0|0 
1 1302799 chr1_1302799_C_A C A 100 PASS --- GT 1|0 
 
11 
can include aspects of morphology (e.g. weight, height); behavior (e.g. aggression, stress); 
physiology (e.g. blood pressure, oxygen saturation levels); as well as molecular phenotypes (e.g. 
gene expression levels, splicing events). If the abundance of a quantitative trait can be associated 
with a specific genetic variant in the genome, then this association can help to understand certain 
diseases associated with the quantitative trait. This process of associating quantitative traits with 
the genotype is called QTL mapping. Whereas phenotypes are represented by quantitative traits, 
genotype information is usually represented as molecular markers, such as single nucleotide 
polymorphisms (SNPs), polymorphic insertions or deletions (indels) or larger structural variants 
(Mackay, 2009). Another powerful feature of QTL studies is the ability to analyse associations in 
various contexts. Quantitative traits can be affected by several properties such as environment, 
sex, diet, cell type, experimental time point or any external stimulus. QTL mapping enables 
researchers to observe the effect of a specific SNP in a specific context which can be compared to 
the effect of the same SNP in another context. For example, the same allele can increase the 
expression of one gene in monocytes but might not affect the regulation of the same gene in B 
cells (Figure 1.5). The output of the QTL mapping process is called summary statistics, because it 
summarises the association information by containing p-values (probability of observing an 
association under the null hypothesis of there is no association), effect sizes and standard errors of 
 
Figure 1.5. Cell type specific effect of the allele to the gene expression. a) T allele of rs2223286 
variant is associated with decreased  expression of SELL gene in B cells, but increased expression 
in Monocytes. b) T allele of rs738289 variant is associated with decreased  expression of MGAT3 
gene in B cells but does not affect regulation in monocytes. Same allele does not affect regulation 
of SYNGR1 gene in B cells but downregulates the expression of it in monocytes. Figure is 
obtained from (Fairfax et al., 2012). 
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it5. Ultimately, summary statistics are compared to variants associated to disease in order to find 
if they are colocalised.  
1.2.6. Colocalisatin 
QTL analysis is becoming increasingly popular in genetic research and they are an excellent 
complement to GWASs. GWASs have become a very powerful method to identify genetic variants 
associated with a complex disease. Nonetheless, most of the significant loci identified by GWASs 
are in the non-coding regions of the genome. This makes it challenging to understand the molecular 
mechanisms underlying these associations (Visscher, Brown, McCarthy, & Yang, 2012). On the 
other hand, QTL studies identify candidate SNPs associated with molecular traits, such as gene 
expression or splicing, but these associations cannot be easily related to the higher level organismal 
phenotypes (e.g. diseases). Several algorithms have been developed to colocalise information of 
eQTL SNPs and GWAS candidate SNPs to deduce the information between disease and gene (J. 
Wang, Zheng, Wang, Li, & Deng, 2019). The underlying idea is that if an allele is more common 
in disease carrier samples and at the same time this allele is found to be associated with the 
expression of particular genes, then it is likely that these genes influence the disease risk through 
changed expression (Figure 1.6).  
Usually there is no single genetic variant in GWAS and QTL associations, but multiple correlated 
variants, simply because they are inherited together. This fact makes difficult to assess if the 
disease and quantitative trait are regulated by the same causal variant. Thus, Giambartolomei et al. 
(Giambartolomei et al., 2014) developed a statistical methodology to assess if the two associations 
are consistent (GWAS and QTL associations) with a shared causal variant. As a result, this method 
enables to infer associations between quantitative traits and disease by using GWAS and QTL 
summary statistics (Figure 1.6). 
                                                 
5
 https://qtltools.github.io/qtltools/pages/mode_cis_nominal.html 
 
Figure 1.6. Association map between genetic variants, quantitative trait and disease. 
Colocalisation uses  QTL and GWAS associations to associate a quantitative trait to 
a disease by finding probable causal variants. 
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1.3. Project Overview 
The work in this thesis contributes to the eQTL Catalogue6, a collaborative project between the 
University of Tartu and the European Bioinformatics Institute. The aim of the project is to compile 
the largest catalogue of genetic variants associated with different transcriptional quantitative traits 
(gene expression, alternative splicing, transcript usage and exon expression) across tissues, cell 
types and cellular contexts. In the project, we aim to process quantitative trait expressions and 
genotype data from more than 23,000 biological samples across more than 18 distinct studies and 
40 distinct biological contexts (“QTL groups”), all of which need to be processed separately for 
QTL mapping (Table 1.2 and Appendix 1). These groups are mostly formed of combinations of 
cell types and conditions (e.g. applied stimuli) of samples. For example, a study by Alasoo et al. 
(Alasoo et al., 2018) exposed human macrophages to Salmonella and IFNγ (interferon gamma) 
stimulations and detected eQTLs whose effect sizes changed after stimulation (response eQTLs). 
With the comparison of different QTL groups they were able to uncover novel molecular 
mechanisms concerning the response of immune cells to environmental stimuli. Ultimately, the 
catalogue allows researchers to query any disease-associated variant to identify associated target 
genes across a range of tissues, cell types and conditions, leading to better hypotheses about 
possible disease mechanisms. 
The eQTL Catalogue is, in essence, a set of QTL summary statistics. To produce QTL summary 
statistics, raw data should be processed through two distinct procedures: quantification and QTL 
mapping. Since multiple datasets and QTL groups from various studies are involved in the project, 
they should be processed uniformly to reduce technical biases and variability between datasets. 
The fact that datasets are big in volume (more than 250 Terabytes) and they should be processed 
by QTL groups necessitates to have a scalable and robust processing method. Additionally, this 
                                                 
6
 https://ensembl.github.io/eQTL-Catalogue-website/ 
Table 1.2: Subset of studies we processed with the pipeline. The QTL group is the combination of cell type 
and condition for each study. For example, BLUEPRINT study has 3 QTL groups and Alasoo_2018 study has 
4. Studies: Alasoo_2018, BLUEPRINT (L. Chen et al., 2016), GEUVADIS (Lappalainen et al., 2013), 
Nedelec_2016 (Nédélec et al., 2016), Quach_2016 (Quach et al., 2016), TwinsUK (Buil et al., 2015). 
Study Donors Samples Cell types Conditions QTL group count 
Alasoo_2018 84 336 macrophage 
naive, IFNγ, Salmonella, 
IFNγ+Salmonella 
4 
BLUEPRINT 197 608 monocyte, T-cell, neutrophil naive 3 
GEUVADIS 462 462 LCL naive 1 
Nedelec_2016 171 503 macrophage naive, Salmonella, Listeria 3 
Quach_2016 200 970 monocyte 
naive, LPS, R848, IAV, 
Pam3CSK4 
5 
TwinsUK 433 1364 LCL, skin, fat, blood naive 4 
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method should support addition of new datasets to the project. The method should also enable to 
process the data in parallel and should support usage of computational clusters. Taking into 
account all the mentioned requirements, we decided to develop a bioinformatics pipeline to 
perform both quantification and QTL mapping procedures. 
A key contribution of the thesis is the development of a robust and portable data analysis pipeline 
that can be run across diverse computational environments. The pipeline allows us to uniformly 
process large datasets in a parallel, scalable and reproducible manner. Additionally, developed 
pipelines are extremely portable which enables to process data hosted on public and private clouds 
without the need to download the data locally. This is especially important for the CINECA 
project7, in which we will jointly analyse gene expression data from multiple large national cohorts 
such as BIOS (Zhernakova et al., 2016) and the Estonian Genome Center (Lepik et al., 2017) where 
sensitive individual-level genetic data cannot leave country boundaries. 
The thesis consists of six chapters. In chapter 2, I will explain the properties of modern 
bioinformatics pipelines, classification of the pipeline frameworks and pipeline design decisions. 
Then, I will describe each step of QTL mapping analysis in detail. In Figure 1.7 the high-level 
representation of QTL summary statistics generation (QTL mapping analysis) from raw RNA-seq 
reads and genotype data is shown. Chapter 3 will contain descriptions of supported quantification 
methods and technical overview of the developed quantification pipeline. After quantification, a 
number of quality control steps should be performed to ensure the high quality of the processed 
data. Post-quantification quality control measures will be extensively described in chapter 4. 
Finally, I will explain all the details of QTL mapping pipeline in chapter 5, including an overview 
of the pipeline, description of the QTL mapping process, description of inputs and outputs, and 
decisions made about the technical implementation. The thesis will end with explanations of 
conclusions of the related work and list of the used studies’ references. 
                                                 
7
 https://www.ebi.ac.uk/about/news/press-releases/CINECA-facilitates-transcontinental-human-data-exchange 
 
Figure 1.7. High level representation of QTL analysis steps. 
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2. Bioinformatics Pipelines 
Due to fast developments in technology, the cost of DNA sequencing has decreased significantly 
since the Human Genome Project (Lander et al., 2001) and the 1000 Genomes project (1000 
Genomes Project Consortium et al., 2015; Siva, 2008) were completed. Now the whole human 
genome can be sequenced for less than $1000. Based on this factor and other technological 
advances, biological data is being generated in large volumes, and it has been accepted as a big 
data field for several years (Y. Li & Chen, 2014). The future of genomics data alone is predicted 
to exceed other big data related fields such as astronomy, YouTube and Twitter by the year 2025 
(Stephens et al., 2015).  
To cope with increasing volumes of genomics data, better and more efficient processing techniques 
are required. To satisfy these requirements, new tools are constantly being developed by academic 
institutions, private companies and government-funded organisations. In data analysis, 
reproducibility is required to enable the validation and consistency of the study results. 
Reproducing the results is easy, if the analysis is performed in a single computer, using a software 
containers such as Docker (Merkel, 2014) and Singularity (Kurtzer, Sochat, & Bauer, 2017), and 
tools like Jupyter Notebooks (Perez & Granger, 2007) and Rmarkdown (Allaire et al., 2016). 
However, genomic data analysis usually has to be run in parallel on compute clusters. This analysis 
has multiple steps that need to be abstracted and coordinated according to the computation 
environment (execution environment, cluster queue systems, software dependencies etc.). 
Eventually, results computed in parallel need to be collated together as output of analysis. In the 
bioinformatics field, this process is called a pipeline or a workflow. In addition to reproducibility 
of the results and task parallelisation, the most important requirements for modern pipelines are 
reusability, portability and dependency isolation.  
2.1. Properties of Pipelines 
To process genomic data, researchers usually shepherd files through a series of specific steps. The 
set of these steps is called a bioinformatic pipeline. Modern pipelines need to have the following 
properties to meet the requirements of modern research. 
2.1.1. Reproducibility (Replicability) 
Processing a dataset at different times, with same set of parameters should produce the same (or 
consistent) results, independent of location and computational environment. This property is 
known as reproducibility of the results and modern pipelines are expected to support it. Nowadays 
the major scientific journals require to publish data and code to assure reproducibility of the study 
results (a.k.a. “reviewable research”, (Stodden, Borwein, & Bailey, 2013)). This requirement is 
reasonable since otherwise, it would not be possible to verify the results presented in the 
publication. The concept of reproducibility is usually referred to in terms of “provenance” (Gil et 
al., 2007; Kanwal, Khan, Lonie, & Sinnott, 2017) which in pipeline circles refers to the origins of 
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input data, tools, results and intermediates (Leipzig, 2018). Replicating (reproducing the results) 
an experiment in a location and operator agnostic manner is a key element in modern science 
(Kulkarni et al., 2018). To reproduce the results of a bioinformatics study, the data needs to be 
accessible and the tools, together with the step-by-step guidelines to reprocess the data, need to be 
available (Usability and archival stability of computational tools).  
Data availability - Genomic data and its privacy are concepts which need very careful attention, 
since misuse of the data can have serious consequences. Genomics is a relatively new field, and 
with the development of biotechnology and increases in computational power, findings are 
happening more frequently in comparison to the previous century. It is not known what can be 
done with the genetic data of the donor in the future and that is why it should be kept according to 
donor’s consent. Taking this potential power of genomic data into consideration, usually, data is 
separated according to donor’s consent to access levels: open access data which is publicly 
available for anyone to use and managed (controlled) access data which needs special permission 
for usage. Hence, if the experiment involves controlled access data, corresponding permissions 
must be obtained to replicate the experiment. 
Usability and archival stability of computational tools - After obtaining the data to be 
reprocessed, the main challenge of replicating an experiment is technical. Usually the problem is 
one of the two following aspects: 
1. The software used in the experiment is not available or can not be installed. A recent 
comprehensive analysis of 24,490 bioinformatics software resources published from 2000 
to 2017 showed that 26% of the tools needed for reproduction were not accessible at all, 
24% of accessible software failed to install and 49% were deemed “hard to install” (Mangul 
et al., 2018). This empirical study also found that the publications introducing new software 
have significantly more citations if they provide an accessible and easy installation process.  
2. The exact guidelines about usage of the software involved in the experiment are 
unavailable. Usually in bioinformatics data analysis, command-line tools are used, where 
each tool executes a specific job according to provided parameters. Providing different 
parameters or not providing the needed parameters can lead to generation of different 
results. Hence, the information about how exactly the software was used in the experiment 
should be provided in order to achieve consistent results. If the used software has multiple 
released versions, it is important to specify which version was used in the experiment, in 
order to ensure the consistency of results. 
Therefore, reproducibility is an essential issue especially because pipelines use several tools. Each 
tool in the pipeline should be accessible and usage of it should be human-readable and 
understandable (explanation comments can be added if the code is not self explanatory, e.g. 
explanation of each parameter used). A pipeline can become useless if even one of the tools is not 
available or produces inconsistent results. 
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2.1.2. Portability 
In data science fields the primary resource is the data itself. It is understandable that some 
organisations do not want to share this valuable resource publicly. In genomics, in addition to the 
value of the resource, there are also legal duties to protect the sensitive data of research 
participants. For these reasons, some authors and institutions simply are not allowed to share their 
genetic data. Genetic data analysis is an incredibly dynamic field, which continuously produces 
new methods, and there is the potential to generate new discoveries by applying new or different 
analysis methods to already existing data. Genetic data generated (sequenced) with one scientific 
question in mind can often be used for another study even if it was not initially generated for it 
(Denk, 2017). However, sometimes, it is challenging to overcome the legal issues to get raw 
genetic data, and that is where the portability of the pipeline plays a vital role. For instance, 
sometimes genomic data cannot be moved outside of a country due to local data protection laws. 
In this case, renting private clouds within the borders of the country and performing the 
computation there with a portable pipeline is an eligible option. Because, even if the sharing of 
raw data is not allowed, the summary-level data analysis results generated from the raw data can 
often be shared with third party organisations or even published publicly, since it is impossible to 
deduce the donors’ private information from the generated results.  
Portability is also appreciated when in an organisation an existing infrastructure changes or some 
other organisation with different technical infrastructure wants to use the pipeline. Being able to 
publish and re-use existing pipelines can significantly improve the efficacy of the data analysis 
process, because researchers do not have to reimplement the same pipelines from scratch and can 
spend more time on interpreting the results. For instance, nf-core (Ewels et al., 2019) is a 
community curated initiative which provides portable and ready-to-use pipelines for public use. 
2.1.3. Scalability 
Each step of the pipeline has specific hardware resource requirements such as memory, time and 
number of needed compute processors (CPU cores) in order to successfully process the specified 
data. When the specified set of resource requirements and data to be processed becomes available 
for executing the step (process) of the pipeline, a task scheduler (e.g. job scheduling systems of 
high performance computing cluster) reserves resources and performs the step. Usually, the 
resource needs of software used in the pipeline are in a linear relationship with the input file size. 
When the needed resources become very large to handle because of the size of the input file, 
software sometimes provides additional options to divide the input file into chunks and process 
them in a parallel manner with less resources but as multiple individual tasks. Therefore, if the 
functionality of the software can scale according to the volume of the input data then the software 
is considered to be scalable. Since the pipeline in essence is a set of tools used in a specific 
configuration, all the tools used in the pipeline should be scalable in order to consider a pipeline 
as scalable (Fjukstad & Bongo, 2017).  
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2.1.4. Dependency Isolation 
It is very common to use existing tools and libraries in software development. That is how a 
developed software becomes dependent on other software. Moreover, if any of the dependencies 
have special needs like a specific operating system or environment, dependent software also 
inherits these needs. When it comes to bioinformatics pipelines, the situation is similar, especially 
when pipelines are script wrappers which use a number of external tools to process and analyse 
data in a structured and efficient manner. Accessibility and stability of software tools used in the 
pipeline increase according to their level of dependency isolation. Consequently, pipelines with 
highly isolated dependencies provide better portability and replicability features. 
We have classified the dependency isolation levels according to their degree from not isolated to 
highly isolated. 
1. No isolation - This is the case when the dependencies and environment needed for the 
execution of the pipeline are only documented in a relevant chapter of the pipeline 
documentation file and it is assumed that the needed tools are waiting in a “ready to use” 
state in the specific environment the pipeline is designed for. Consequently, any change to 
the software environment can cause the pipeline to fail (Baggerly & Coombes, 2009; 
Ioannidis et al., 2009) or generate inconsistent results due to different versions of the 
software tools used (Piccolo & Frampton, 2016). Typically, single script file pipelines are 
good examples of this, where all tasks and their order, environment-dependent 
configurations, and parameters of tools used in the tasks are defined in a single file. Thus, 
if the working environment changes, the change of the pipeline file becomes inevitable.  
2. Isolate workflow logic from the execution environment - When the pipeline is hardcoded 
to communicate with a specific cluster environment, running it in a different environment 
takes a lot of effort. However, if the workflow logic and execution environment 
configuration are isolated, it requires no change in the workflow logic. Usually, workflow 
frameworks offer easy-to-set configuration options to run the pipeline in a different 
execution environment. This isolation level still requires manual installation of software 
required by the pipeline, but isolation between workflow logic and the execution 
environment is guaranteed. It means that if a user has a workflow and the needed 
dependencies are installed, a pipeline can be executed with any executor by only changing 
the configuration file and keeping the workflow logic unchanged. That is a good feature to 
have, especially since there is a number of different computing  platforms that can be used 
such as SGE, SLURM, LSF, PBS/Torque, NQSII, HTCondor, AWS Batch, Ignite, 
GA4GH TES and Kubernetes. 
3. Conda integration - Conda is a package, dependency and environment manager, which can 
be used on all major operating systems8. Conda downloads software packages from defined 
channels and installs them into an isolated environment. That is a good way of isolating 
dependencies for several reasons. Firstly, it is enough to provide a recipe for needed 
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dependencies and Conda will take care of creating an environment with the provided recipe 
(Figure 2.1). Therefore, researchers with less software experience will not have difficulties 
running the pipeline, and there is no need to provide the dependency itself but only the 
recipe. It is also possible to manually add scripts to a created Conda environment, which 
enables local testing of the developed script in an isolated environment, but in return it 
decreases the portability of the pipeline. Additionally, Conda is an open source initiative, 
so that anyone can contribute their own software package to it. Finally, it has a very well 
tested package repository, which guarantees the stable performance of a specific version 
of a specific tool. However, Conda environments do not contain an isolated operating 
system, and some packages are not available for all operating systems, which limits the 
portability of Conda environments and makes it inferior to containerised isolation.  
4. Containerisation - Nowadays the best-known dependency isolation is done by containers. 
Containers contain all the needed software to run the pipeline. It is different from Conda 
because containers keep the software itself and not the recipe of it. There are some 
advantages of containers over other dependency isolation methods. First, containers are 
extremely portable and can make dependencies of a pipeline highly accessible. 
Consequently, given that the execution environment also supports containerisation 
technologies, containerised pipeline dependencies will enable portability and 
reproducibility of the pipeline, basically by easily accessing the dependencies provided 
within container. As in Conda-like isolation, manually adding custom scripts to a container 
is also possible, and is not limiting the portability of either the container or the pipeline. 
Although it is possible to manually build “black-box” containers, this approach is not 
advisable. Because, even though the pipeline is reproducible (produces the same results 
when rerun), it is not possible to verify what the custom software actually does in the 
container. Thus, in order to provide the exact content (tools with corresponding versions) 
of the container, the recipe used to build it should be also provided. Currently, the most 
popular software container tools are Docker (Merkel, 2014) and Singularity (Kurtzer et al., 
2017). Typically, the software containers are built using a recipe file (e.g. Dockerfile) 
which contains the base image and step-by-step instructions about how to build the 
container. The base image is a previously built container, usually containing basic needs 
of a container such as an operating system. However, the nf-core initiative provided a base 
 
Figure 2.1. Example of Conda environment recipe file. 
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image with an operating system and Conda software installed, together with a Dockerfile 
and Singularity recipes to use the provided base image. Using these provided resources 
makes it straightforward and painless to build the container with a Conda-like recipe. For 
instance, to build a Docker container, Docker software creates a container with base image 
which contains an operating system and Conda, and creates a Conda environment with 
provided Conda-like recipe inside the container. Hence, if the pipeline provides a Conda-
like recipe for creation of Conda environment, it is possible to easily build a software 
container with the same provided recipe. After building the container, storing it in a specific 
web repository like Docker Hub9 or Singularity Hub10 is an easy and common way of 
storing and sharing containers. Since the container hubs are open for public, it is possible 
to pull and use already existing containers in the hub. Docker is essentially designed for 
use of enterprise software production systems and it gives superuser privileges to the user. 
In multi-user systems such as HPCs, there is no good way of restricting users with such 
privileges from accessing other users’ data. Singularity, another containerization platform, 
behaves like Docker but does not require administrative privileges to be used (Silver, 
2017). Finally, with containerisation it became relatively easier to automate the testing of 
dependencies. Continuous integration and delivery are vital for most software development 
organisations and containerisation provides an opportunity to apply well-known practices 
of dependency isolation and continuous integration to bioinformatics pipeline 
development. 
2.1.5. Parallelisation 
Genomic data files usually are large collections of short reads (~100 base pairs, depending on the 
sequencing platform). Reads are the sequences of characters read out from the DNA. There are 
several steps in a pipeline to process these files and extract meaningful information. Some of these 
steps should be performed in parallel to achieve high efficiency in terms of time and cost. 
Nowadays, even personal laptops usually have more than one multi-core CPUs which can run jobs 
in parallel. However, to host these parallel operations there are High Performance Computing 
(HPC) clusters specifically designed to increase the throughput of scientific analysis. HPCs’ 
operating systems are usually Linux based and have job scheduling systems (also called executors) 
which orchestrate jobs into different nodes to be processed. Each job has its own resource needs, 
and scheduling systems should use the resources in an efficient way to meet these needs. For 
instance, given that there are ready-to-use sufficient hardware resources, from the user’s point of 
view, the total running time of the pipeline for processing either 2 or 200 samples should not differ 
greatly.  
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Computational power can also be outsourced if an institution does not want to maintain this 
computational infrastructure by themselves. Cloud batch computing services are gaining more and 
more popularity for the following reasons:  
● Users do not have to think about maintenance of the cluster since service providers take 
care of it.   
● In bioinformatic analysis, lots of huge reference files are used. Storing these files also has 
costs. Some cloud batch computing services keep these reference files in common storage 
which means that anyone can use them without paying extra (Yung et al., 2017). 
● Since transferring the files can also be costly, it is usually a good idea to keep the raw data 
close to the computing power. That is why these services also offer private storage options 
to keep the raw data in the cloud. Furthermore, some large-scale genomics project such as 
The Cancer Genomics Atlas have made their data available on the cloud, removing the 
need for analysts to download hundreds of terabytes of raw data11.  
● Cloud services usually offer different pricing options, and usually, a user pays only when 
they use it. For instance, AWS Batch calls it the “Pay-as-you-go” approach12. This also 
makes cloud systems extremely scalable. 
On the other hand, cloud systems also have some drawbacks. The major reasons why some 
institutions decline to use cloud services are the cost of the service and security of their data. First, 
if there is a high demand to continuous service of computational power in an institution, it is 
usually cheaper in a long term to acquire inhouse HPC. Secondly, although cloud service providers 
ensure to keep users’ data safe, some research institutions do not prefer to use these services due 
to the potential issues described in (Kandukuri, V., & Rakshit, 2009). 
2.1.6. Reusability 
There are two contexts to evaluate the reusability of a pipeline: reusability of a pipeline by end-
users and reusability of the pipeline by other developers. 
Reusability of a pipeline by end-users - Although there are already multiple options for biologists 
to gain enough informatics knowledge to use bioinformatics software and interpret its results, 
bioinformatic pipelines should be designed such that minimum configuration change would be 
enough to run it successfully. In this context, reusability means how easy it is for users to install 
and execute the pipeline on their own data. The bioinformatics pipeline is considered to be reusable 
if the the user without prior knowledge of the field can use the pipeline with minimal effort. 
Additionally, it is acceptable to allow the users to change parameters of the pipeline in order to 
make it better fit to their data and execution environment. Therefore, giving some options to 
change the parameters is considered as flexibility of the pipeline, which in return increases the 
reusability of it. Currently, there is no consensus test to measure the reusability of a bioinformatics 
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pipeline, that is why feedback provided by users and popularity in the community are considered 
to be the main measures. 
Reusability of the pipeline by other developers (a.k.a. extensibility) - Researchers could want 
to use an existing pipeline as a basis for the development of new pipelines. In this context, 
reusability means how easy it is for developers to extend a pipeline or use the source code of a 
pipeline for development of a new one. The adoption of a “pipeline step modularisation” approach 
by most institutions made it common to reuse these steps in other studies (Leipzig, 2018).  
Open Source Software (OSS) movement is one of the major powers of software engineering 
nowadays (Carillo & Okoli, 2008). The main beneficial properties of OSS are transparency, easy 
collaboration and an immense knowledge pool (Dabbish, Stuart, Tsay, & Herbsleb, 2012). The 
bioinformatics field also used the benefits of the shared development platform. Various institutions 
have proclaimed developing reusable, robust and open source bioinformatics pipelines as one of 
their objectives (e.g. (Ewels et al., 2019)). Another benefit of OSS is the community support which 
is usually provided by code repository issues, chat channels like Gitter13, free agile development 
tools like Slack and Trello and mail groups. With the help of these communication channels, users 
and developers get quick help on how to use and develop the pipelines, and the main contributors 
get rapid feedback which results in bug fixes and development of new features.  
2.2. Comparison of Pipeline Frameworks and Design Decisions 
Some well-known pipelines have been collected in the public repository (Di Tommaso, awesome-
pipeline). These pipelines have differences regarding design philosophies, technical issues, 
difficulty of usage, environment dependency and some other factors. To get a broader view of 
bioinformatics pipelines a review study by Jeremy Leipzig (2017) classifies existing pipelines 
according to three criteria: syntax, paradigm and interaction.  
2.2.1. Classification of Pipelines 
Syntax - Explicit frameworks following the idea of tightly linking the tasks together in a certain 
order and providing inputs to the very first task in order to be processed in a fixed-order chain of 
tasks. Not relying on input names, output names and transformation rules between them makes 
explicit frameworks simple and robust but limits the flexibility of the pipeline to process the newly 
added files in addition to already processed ones. Galaxy (Goecks, Nekrutenko, Taylor, & Galaxy 
Team, 2010), Taverna (Wolstencroft et al., 2013) and Ruffus (Goodstadt, 2010) are good examples 
of explicit paradigm using pipelines. On the other hand, in the implicit syntax frameworks, it is 
sufficient to specify inputs and expected outputs (target files), and intermediate steps are calculated 
automatically by the framework. Hence, the order of tasks is managed implicitly by the framework 
and not hard-coded by the user (Figure 2.2).  
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Implicit frameworks are mainly descendants of Make which was designed in the '70s as one of the 
early developed domain specific languages (DSL). Make offers a set of rules and a symbol-based 
syntax which define how input files will be transformed into outputs, and output files will feed the 
next step with inputs and so on. The implicit DSLs’ crucial feature is reentrancy, i.e. ability to 
distinguish already processed files and not reprocess them. It checks the modification date of the 
input file and compares it to the modification date of an existing output file. If the target file exists 
and the input file is older than the target file, Make considers it as an already processed file. 
Reentrancy is vital for a pipeline development process when potential errors are expected and 
recovering from them takes less time thanks to this ability. Some implicit frameworks such as 
Nextflow (Di Tommaso et al., 2017) and Snakemake (Köster & Rahmann, 2012) follow the Make 
concept with the support of full-featured programming languages, respectively Groovy and 
Python. Snakemake, as a faithful follower of Make, is file-centric, whereas Nextflow introduces 
channels to pass intermediate forms of steps to each other which eliminates the need of tagging 
intermediates with complex file suffix names (Leipzig, 2018). In Nextflow, input and outputs are 
typed values which offer more flexibility concerning keeping intermediates in memory while 
ensuring reentrancy with caching.  
Design Paradigm - DSLs are known to be designed based on a conventional design paradigm, 
when a directed acyclic graph (DAG) is dynamically generated according to the syntax rules of 
the language, input files and target files. On the other hand, explicit frameworks create DAGs with 
the help of APIs or visual user interfaces. Explicit frameworks’ DAG structure is static, where an 
ordered chain of tasks is described in a fixed XML or JSON format, and changing the provided 
 
Figure 2.2. a) Symbolic representation of explicit pipeline frameworks. The tasks are tightly coupled in 
a specific order. Input file is processed step by step in a chain of ordered tasks to produce an output file. 
b) Symbolic representation of implicit pipeline frameworks. There is no fixed order of tasks. Instead, 
framework calculates intermediate steps according to provided target file and input file. 
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input does not change the structure of generated DAG. Hence, explicit frameworks are considered 
to be members of configuration-based paradigm. Another design paradigm called class-based 
paradigm covers design principles of frameworks that are bounded to an existing code library 
instead of independent executables. More detailed analysis of design paradigms is provided in 
(Leipzig, 2017).  
Interaction - In contrast to command-line based pipeline frameworks, workbenches provide users 
with a graphical user interface. In this interface, the user can add nodes (pipeline tasks - 
preconfigured modular tools) and connect them (representing the data flow - the outputs of the 
previous step become the input of the next) to develop a pipeline. These kinds of frameworks are 
very suitable for scientists who have an understanding of the expected input and output files but 
have a little or no coding experience. One drawback is that existing modular steps have to be 
sufficient for the analysis. Open source workbenches can be installed both locally and in the cloud. 
These workbenches convert a  graphically designed pipeline to a configuration-based pipeline in 
the background. With their large number of options, Galaxy (Goecks et al., 2010) and Taverna 
(Wolstencroft et al., 2013) are the most popular ones. Galaxy offers a web-based interface for 
command-line tools. Galaxy’s interface is easy to use, but it needs some coding skills to add new 
modules. Taverna, on the other hand, allows pipelines to reach tools distributed across the Internet 
and needs more development skills to develop new plug-ins (modules). There are some 
commercial cloud-based Software as a Service (SaaS) workbenches such as Illumina’s 
Table 2.1. The classification of modern pipeline frameworks. Table 
is obtained from (Leipzig, 2017) and used without modifications 
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BaseSpace14, SevenBridges15 and DNANexus16. Cloud-based services like these make the pipeline 
reusability, sharing and collaborations easier. To sum up the findings, the tabular representation of 
the modern pipeline frameworks’ classification made by Jeremy Leipzig (Leipzig, 2017) is shown 
in Table 2.1.   
2.3. Pipeline Requirements of the Project 
Having a variety of pipeline development frameworks providing number of different features 
makes it difficult to choose the best among them. One pipeline framework can be highly scalable 
but lack flexibility to modify the pipeline by the users. Therefore, a pipeline framework should be 
chosen according to the specific needs of the project. Our project requires that the pipeline to be 
developed should have the following features: 
1. Pipeline should be portable between a wide range of different compute environments. It 
can be developed and prototyped in the HPC at University of Tartu, but it should be able 
to run in other environments such as EBI Embassy Cloud17, Google Cloud18 and HPC 
environments of our partners with minimal effort. Next release of GTEx (GTEx 
Consortium, 2013) will be distributed using Google Cloud and is expected to contain 160 
terabytes of data. Portability of pipeline should enable the analysis of this data without 
downloading it locally, which can take several weeks and requires lots of local space. 
2. Pipeline should be able to handle large volumes of data. The volume of genomic datasets 
is continuously increasing and performance of the pipeline should scale accordingly. 
3. Pipeline should support reentrancy. Processing time of datasets is usually correlated with 
their size. Thus, processing large datasets can take considerable amount of time. If the 
execution of a pipeline is stopped for any reason, rerunning the pipeline should not 
reprocess already processed entities, but should resume from the point it stopped at. 
4. Pipeline should be robust to disruptions in computation. Even in very sophisticated systems 
disruptions of computation can occur. Pipeline should able to handle the exceptions and 
resubmit the interrupted tasks. For instance, usually each individual process of a pipeline 
has specific resource requirements, such as number of processors and memory. Sometimes 
specified resources can become insufficient due to abnormal size of an intermediate file, 
and consequently the task can stop running. Pipeline should understand the nature of the 
error message and increase the specified resource requirement for that specific task 
instance. 
5. Pipeline should be reproducible. Running the pipeline in two different execution 
environments (at different times) with the same input and parameters should result in the 
exact same results.  
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6. Pipeline should be inspectable. All the steps of the developed pipeline should be open-
source, human-readable and understandable.  
7. Execution of pipeline should be traceable. Usually the final target files are the main point 
of interest in pipeline execution. However, in order to produce target files, vast amount of 
intermediate files are generated, and sometimes intermediate files play an important role 
in understanding unexpected content of target files. Furthermore, intermediate files can be 
used as inputs of third party tools in order to empower the data analysis with additional 
information. Thus, the pipeline should gracefully handle large numbers of intermediate 
files and automatically delete them when specified to do so.  
8. It should be easy to install and run the pipeline. For instance, support of software containers 
and Conda environments should be provided to minimize the effort to set up the execution 
environment. 
9. Pipeline should follow the best practices of the pipeline development process. Maintenance 
is crucial for longevity of the pipeline. To minimize the effort spent on maintenance, best 
practices should be applied. Best practices are evolved according to needs of the user and 
developer communities. Used framework should have a community who has already 
developed such pipelines and has experience with best practices to be followed.  
10. Pipeline should be reusable and extensible. Modern pipelines should adapt to the new needs 
of the the user community. Hence, the pipeline should be open and eligible to modifications 
and extensions by developers in order to change used tools or to add new features. 
11. Pipeline should support continuous integration. Although usually there is a main developer 
and maintainer of the pipeline, open-source projects are often also changed by other 
developers. To ensure the functionality and the quality of the project, automatic tests are 
performed after each modification and the changes are added to the repository only after 
all tests have passed.  
2.3.1. Comparison of Most Popular Frameworks 
Fortunately, the evolution of pipeline design already serves us good frameworks to develop 
pipelines which provide all of the listed properties. Nonetheless, we have different options 
concerning which framework to use for pipeline development, each pipeline framework has its 
own benefits and drawbacks, and there is no formula to prefer one over the another. A suitable 
framework can be chosen according to the specific goals of the project. The most popular 
frameworks to construct bioinformatics pipelines are Nextflow, Snakemake and Galaxy. Table 2.2 
shows the overall comparative properties of these frameworks. As it can be seen from the table, 
there are no significant differences between the frameworks. All three of them support the main 
features of modern pipelines (e.g. dependency isolation, reentrancy, scalability, reproducibility), 
and that is the reason why they are most popular among others. However, Galaxy is different from 
the other two, being designed for users with little or no coding skills. Being less extensible, lacking 
flexibility of changing hard-coded tool requirements (e.g. needed computational resources) and 
exception handling makes this configuration based framework a weaker candidate for this project. 
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Nextflow and Snakemake are similar frameworks because of their design paradigm. However 
Nextflow, in comparison to Snakemake supports exception handling and has a better community 
providing best practices to easily develop a pipeline from scratch (Ewels et al., 2019). 
Additionally, Nextflow provides a better reentrancy feature based on caching, making debugging 
issues easier and intermediate files inspectable. Snakemake, on the other hand, makes it easier to 
iteratively develop and document data analysis projects, because all of the intermediate files are 
stored in an explicit folder structure.  
Table 2.2. Comparison of three most famous pipeline frameworks. The evaluation of properties with count of 
stars (*) is highly subjective and current values originate from the performed literature review and personal 
experience of the author. 
 Nextflow Snakemake Galaxy 
Syntax Implicit Implicit Explicit 
Paradigm Conventional Conventional Configuration 
Interaction Command-line Command-line GUI Workbench 
Dependency isolation Conda, Docker and 
Singularity 
Conda and Singularity Conda, Docker and 
Singularity 
Dynamic Exception 
Handling 
Supported Not supported Not supported 
Reentrancy Supported by using 
caching 
Supported by tracking 
file names and 
modification times 
Support as a built-in 
feature with less 
flexible options  
Scalability *** *** *** 
Reproducibility *** *** *** 
Extensibility and 
Ease of development 
*** *** * 
Inspectability *** *** ** 
Community, 
availability of best 
practices, CI and 
documentation 
*** * ** 
Flexibility *** *** * 
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2.3.2. Pipeline Design Decisions 
Taking into consideration the existing needs of the project, we decided to use the implicit  DSL, 
command-line based script wrapper Nextflow (Di Tommaso et al., 2017) for the following reasons: 
● It is straightforward to install and run. 
● It offers an excellent framework to develop executor and environment agnostic pipelines. 
Nextflow follows “develop once and run everywhere” approach which is extremely 
suitable for our needs since our pipeline should be able to run with many executor engines 
including cloud clusters.  
● It provides good integration with containers like Docker and Singularity, and popular 
package manager Conda (Grüning et al., 2018).  
● It has a very helpful community and easy-to-communicate channels to get help rapidly. 
● There are open-source projects like nf-core19, which provide ready-to-use pipelines that we 
can adopt and make modifications according to our needs. Nf-core provides also a 
collection of best practices and reasonable defaults for pipeline developers. 
● It has good error handling features which make pipelines robust. In bioinformatics 
pipelines each step has minimum resource requirement. In case the process (step) raises an 
error due to resource insufficiency, nextflow provides an option to automatically resubmit 
the task with increased resource requirements. 
● It provides reentrancy feature using the caching, which enables to track intermediate files 
of a particular process. This feature is extremely useful in development stage when a lot of 
debugging actions are required. 
● It provides a good feature for pipeline versioning which increases reproducibility. 
● Continuous integration and continuous testing tools such as Travis CI20 can be easily 
implemented with Nextflow pipelines. 
● Steps (tasks) accept scripts of any scripting language as long as the needed language is 
installed (or provided within a container) and ready-to-use in the pipeline running 
environment. 
● Distinction between intermediate files and final outputs is clear. Final outputs can easily 
be stored in a permanent location without explicitly removing intermediate results. This is 
especially important for quantification pipeline that can produce terabytes of intermediate 
results whereas final outputs are very small. 
3. Quantification Pipeline 
The long term goal of the eQTL Catalogue project is to contain not only eQTLs (gene expression 
QTLs) but also transcript usage (tuQTL), alternative splicing QTLs (sQTL) and exon expression 
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(eeQTL). To be able to detect these QTLs, we first need to quantify gene expression, transcript 
usage, alternative splicing usage and exon expression from RNA-seq data (Figure 3.1).  
3.1. Quantification Methods 
Several tools have been developed for quantification of these phenotypes (Figure 3.1) (Anders, 
Reyes, & Huber, 2012; Dobin et al., 2013; Kim, Langmead, & Salzberg, 2015; Liao, Smyth, & 
Shi, 2014). Every one of these tools serves to solve a particular problem to reach the common goal: 
to produce a phenotype matrix of a quantitative trait (Table 3.1). Additionally, there are already 
well established pipelines which use a subset of these tools and produce count matrix of one 
phenotype21,22. However, currently there is no public, uniform pipeline which takes the RNA-seq 
raw data and quantifies multiple quantitative traits such as transcript usage, exon expression and 
alternative splicing usage in addition to gene expression. We adopted the nf-core rna-seq pipeline23 
for gene expression, and added the following new quantification methods: 
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 https://usegalaxy.org/u/chmy/w/rna-seq-differential-analysis 
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 https://github.com/Novartis/EQP-cluster 
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 https://github.com/nf-core/rnaseq 
 
Figure 3.1. Description of counting reads as gene expression, transcript usage, exon expression and splice-junction 
usage. A gene described in example has 2 transcripts, 3 exons and 3 different splice junctions. a) All reads mapping 
to the gene are summed together to estimate gene expression. b) Reads are assigned to the transcripts that they are 
most likely to originate from. c) Expression level of each exon is quantified separately. d) Reads mapping to splice-
junctions are used to distinguish between two alternatively spliced transcripts. 
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● Transcript usage 
● Exon expression 
● Alternative splicing usage 
To quantify gene expression, exon expression and alternative splicing usage, RNA-seq reads 
should be aligned to the reference genome to determine the location from which they are 
originated. STAR (Dobin et al., 2013) and HISAT (Kim et al., 2015) are well-known RNA-seq 
aligners, using different algorithms to achieve the goal. STAR uses suffix arrays to provide fast 
aligning, however requires a large amount of random access memory (~27 GB of RAM) to 
function. HISAT, on the other hand, uses an indexing approach based on the Burrows-Wheeler 
transform (M. Burrows, 1994) and the Ferragina-Manzini (Ferragina & Manzini, 2000) index, and 
requires less memory, making it possible to align reads even in personal computers (Kim et al., 
2015). Aligner tools take the raw RNA-seq data (FASTA/FASTQ format (Cock, Fields, Goto, 
Heuer, & Rice, 2010)) and the reference genome file (FASTA format) as inputs and output aligned 
sequence files (SAM/BAM format (H. Li et al., 2009)) and some additional files with metadata. 
To quantify transcript usage, we used Salmon (Patro, Duggal, Love, Irizarry, & Kingsford, 2017) 
which does not align reads to the reference genome, but uses the reference transcriptome instead 
(nucleotide sequences of all transcripts on the reference chromosomes, FASTA format). 
3.1.1. Gene Expression Quantification 
Gene expression is the most commonly used quantification method in RNA-seq analysis. It 
corresponds to the total number of RNA-seq reads mapping to the gene (Figure 3.1a). We use the 
rnaseq pipeline24 developed by the nf-core (Ewels et al., 2019) community. This pipeline provides 
two alignment options: HISAT and STAR, preprocessing and quality assurance tools like fastqc25, 
cutadapt (Martin, 2011), trim_galore, (Krueger, 2015), preseq26, RSeQC (L. Wang, Wang, & Li, 
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 https://github.com/nf-core/rnaseq 
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 https://www.bioinformatics.babraham.ac.uk/projects/fastqc/ 
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 http://smithlabresearch.org/software/preseq/ 
Table 3.1. Example of quantified phenotype matrix of gene expression. First two columns contain 
phenotype information (ID and length of the phenotype). Starting from third column, each column name 
represents the sample ID and column values represent expression level of the corresponding phenotype. 
gene_id length UCF018 UCB018 UCT018 UCB019 UCT019 UCB024 
ENSG00000223972 1735 0 0 0 0 0 0 
ENSG00000227232 1351 3 8 14 8 10 22 
ENSG00000233750 3812 0 1 0 0 2 1 
ENSG00000268903 755 1 7 9 11 0 25 
ENSG00000279457 1397 11 31 16 29 29 28 
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2012), picard tools27, dupRadar (Sayols, Scherzinger, & Klein, 2016) and multiQC (Ewels, 
Magnusson, Lundin, & Käller, 2016). To summarise aligned reads, the pipeline uses the 
featureCounts tool: an efficient program for assigning sequence reads to genomic features. (Liao 
et al., 2014).  
3.1.2. Transcript Usage Quantification 
To estimate the relative expressions of alternative transcripts (Figure 3.1b) we used Salmon (Patro 
et al., 2017). Quantifying with Salmon consists of three steps: building a salmon index, 
quantification of transcripts and merging the outputs. To build a salmon index, the only needed 
input is the reference transcriptome (FASTA file). For quantification, Salmon takes the built index 
and one raw RNA-seq (FASTQ) file as inputs and estimates the expression of each transcript. 
Salmon is able to quantify individual reads in the FASTQ file in parallel using multiple threads. 
Salmon quantification output contains transcript id, length, effective length, counts per kilobase 
million (TPM normalised count) and number of reads assigned to the transcript. At the end, when 
the transcript expressions of all RNA-seq samples are quantified, independent output files are 
merged into a single phenotype matrix file (Figure 3.2).  
3.1.3. Exon Expression Quantification 
To quantify exon expression levels in RNA-seq data (Figure 3.1c) we used the DEXseq (Anders 
et al., 2012) package from Bioconductor. DEXseq takes an aligned reads (SAM) file and counts 
the number of reads mapped to a specific exon of the gene. Technically, DEXseq consists of a pair 
of python scripts: one to prepare DEXseq annotation file and another for counting reads mapped 
to exons. To build an annotation file, DEXseq needs Gene Transfer Format (GTF) file. It processes 
the exons in GTF file and creates a customized exon annotation file (General Feature Format - 
GFF) where exons do not overlap each other. The second script takes the built annotation file 
(GFF) and aligned RNA-seq reads (BAM), and counts the reads overlapping with new custom 
exons in the annotation file. Each aligned file is quantified individually, therefore the counting 
step produces output for each sample. When exon usage counts are quantified for all samples, 
output files are merged into a count matrix file (Figure 3.3). 
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Figure 3.2. High-level representation of transcript usage quantification with Salmon. 
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3.1.4. Alternative Splicing Usage Quantification 
Although multiple tools exist to quantify alternative splicing events (Goldstein et al., 2016; Griffith 
et al., 2010; Trapnell et al., 2012), we prefered to use LeafCutter (Y. I. Li et al., 2018) which 
directly measures splice-junction usage and does not rely on known transcript annotations. Splice-
junction usage is a way to quantify alternative splicing from the RNA-seq data by looking at RNA-
seq reads where one half of the read maps to one exon and the other half to another exon, revealing 
the intron that has been spliced out (Figure 3.1d). LeafCutter takes the aligned reads as input 
(BAM) and detects the differences in intron excisions for each input file and clusters them 
according to their junctions (Figure 3.4). This cluster of the different intron excisions is the final 
output (a.k.a. phenotype count matrix) of the LeafCutter tool.  
3.2. Pipeline overview 
The implemented RNA-seq quantification pipeline quantifies all the listed phenotypes in a parallel 
manner to achieve high efficacy in terms of cost and time. Raw RNA-seq sample reads go through 
Quality Control steps and are pre-processed to become ready for further processing. Pre-processed 
sample reads can go directly to transcript expression quantification, however, they  should be 
aligned to the reference genome for gene expression, exon expression and alternative splicing 
usage quantifications. In the quantification step, prerequisite resources of each tool (featureCounts, 
DEXseq, Salmon and LeafCutter) are already prepared and are ready to be used (not shown in 
Figure 3.5). Each aligned sample is quantified individually and a count matrix is generated for 
each sample. When the outputs of all samples for one quantification type have been generated, 
they are merged together to form a merged phenotype count matrix (Figure 3.5).  
 
Figure 3.3. High-level representation of exon expression quantification with DEXseq. 
 
 
Figure 3.4. High-level representation of splice-junction usage quantification with LeafCutter. 
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In addition to features that are provided by Nextflow as a framework, adapting the nf-core pipeline 
according to our needs has a number of benefits. First, since nf-core pipelines are actively 
maintained by the community, the tools used in the pipelines are up to date. Secondly, they 
provided well documented guidelines including best practices including a tool28 to simplify the 
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Figure 3.5. High-level representation of quantification pipeline including four different 
phenotype quantification method descriptions. 
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pipeline development process and a base container image to ease building software containers 
(Docker and Singularity) using a Conda environment recipe. Integrating the Travis CI29 tool 
enabled to easily support the continuous integration of pipeline changes. Finally, the nf-core rnaseq 
pipeline30 is one of the first developed pipelines by nf-core community, hence it continuously 
evolved applying the best known practices. It is currently used by many sequencing facilities such 
as SciLifeLab31 and Wellcome Sanger Institute32, which gives additional confidence to adopt this 
pipeline as a base for our pipeline. 
We did not modify the existing gene expression quantification steps, but added three more 
quantification methods into the pipeline. We followed the best practices and added the necessary 
documentation about usage of the pipeline. The pipeline is freely available for download from 
GitHub33.  
4. Quality Control and Normalisation 
Assessing data quality is essential in studies that contain hundreds of independent samples, 
because low quality samples can manifest as extreme outliers in the dataset. Outlier samples can 
in turn significantly reduce the power of detecting QTLs (Ellis et al., 2013) or skew the overall 
result of the analysis. Furthermore, sometimes two or more samples contaminate each other due 
to minor human errors in the laboratory, so that genetic material from the sample of one individual 
is present in a sample of another individual. This error is called sample cross-contamination and 
can also reduce power to detect QTLs. Therefore, in addition to pre-quantification quality control 
(QC) steps, we applied post-quantification QC measures such as Principal Component Analysis 
(Wold, Esbensen, & Geladi, 1987) and Multidimensional Scaling (Cox & Cox, 2000; Kruskal, 
1964) to detect outliers, and sex-specific gene expression analysis (’t Hoen et al., 2013) and 
sequence-genotype matching analysis (Fort et al., 2017) to detect contaminated and swapped 
samples. To apply these QC measures, estimated feature counts should be normalised according 
to the quantification method. For instance, we used Transcript Per Million (TPM) (Wagner, Kin, 
& Lynch, 2012) method to normalise gene expression and transcript expression counts, and filtered 
out lowly expressed phenotypes (median(TPM) < 1), because lowly expressed phenotypes usually 
do not contribute much to the meaningful signal, but considerably increase the level of noise. 
Although the script that produces these QC figures and tables is automated, we have decided to 
keep the process of identifying low quality samples and resolving conflicts between sample 
identities between RNA-seq and genotype data manual, because extracting thresholds for these 
decisions are often dataset specific and require human judgement. 
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4.1. Principal Component Analysis (PCA) 
PCA is a linear dimensionality reduction method which aims to collect most of the variance in a 
multidimensional dataset inside the principal components. As a result, it becomes possible to plot 
most of the variation and see if there are any samples in the dataset that look like obvious outliers. 
PCA is one of the most commonly used procedures to summarise a multivariate dataset and detect 
outliers in sample population.  
The BLUEPRINT dataset consists of 608 samples from three distinct cell types (monocytes, T-
cells and neutrophils) that form three distinct clusters in the PCA analysis (Figure 4.1). This dataset 
has no sign of any outlier sample which means PCA analysis did not find any poor quality samples 
to be eliminated from the dataset. Some studies contain several cell types or conditions, whereas 
others focus on only one cell type and have only one (naive) condition (Appendix 1). One such 
dataset is the collection of human induced pluripotent stem cells (iPSCs) generated by the HipSci 
project (Kilpinen et al., 2017). A PCA plot of the latter type of datasets usually look like Figure 
4.2: one big cluster of samples without clear boundaries. The two outliers marked with a circle in 
plot are different than other samples. Principal component 1 values of these outliers differ from 
the cluster of other samples. This fact necessitates to look for the reason of this variance, which 
results in the decision of if the sample will be excluded from further processing with the QTL 
mapping pipeline or not. Usually, in outlier analysis, the reason of the variance is not evident (e.g. 
low sample quality, library preparation errors, sequencing errors, etc), and it is impossible to 
enhance the quality of the outlier samples (correct the unknown variance). Similarly, we could not 
find the reason of the variance of these two outliers and decided to exclude them from the dataset. 
 
Figure 4.1. PCA plot example from BLUEPRINT dataset (no outliers). 
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PCA of the TwinsUK dataset (Buil et al., 2015) reveals four obvious clusters which represent the 
four cell types and tissues that were profiled (blood, fat, skin and lymphoblastoid cell lines (LCLs)) 
(Figure 4.3). Samples marked with a highlighted circles appear to be outliers with no obvious 
reason, and we decided to remove them from the dataset. 
PCA is a well-recognised and easy to perform method to find outliers in the data. However, when 
the data is about biological signals, usually PCA explains only a fraction of information in two 
principal components. For instance, in Figure 4.2 only 28.5% of all variance is explained in the 
first two principal components. Although in this case it is sufficient to recognise outliers, 
sometimes it is beneficial to explore also more (e.g. third and fourth) principal components.  
 
Figure 4.2. PCA plot example from HipSci dataset. Samples SAMEA2397802 and SAMEA2398792 are outliers.  
 
 
Figure 4.3. PCA plot example from TwinsUK dataset. Samples TWPID8405_S, 
TWPID12889_S, TWPID2140_F, TWPID11605_B and TWPID10593_B are outliers.  
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4.2. Multidimensional Scaling (MDS) 
MDS is an exploratory technique used to identify unrecognized dimensions of the dataset 
(Mugavin, 2008). MDS reduces a multidimensional dataset to relatively simple, easy-to-visualize 
structures, which helps us to identify outliers after plotting and analysing it. In contrast to PCA, 
MDS can perform a non-linear dimensionality reduction using distances between each pair of 
samples. It can also force all of the data into a small number of dimensions (e.g. two dimensions) 
that simplifies visualisation. In contrast, since principal components are by definition orthogonal 
to each other, complex datasets are often not adequately summarised by the first two principal 
components. After reducing the phenotype count matrix into two dimensions using MDS, we 
explored outliers. TPM (Wagner et al., 2012) values were used in log2-transformed (log2(0.1 + 
TPM)) scale, after filtering out lowly expressed phenotypes (median(TPM) < 1). Pearson 
correlation was used as the correlation measure and distances between samples were defined as 
distance = 1 - correlation. We used isoMDS function from MASS R package (Cox & Cox, 2000; 
Ripley, 2007; Vernables & Ripley, 2002) with two desired dimensions (k=2) to summarise the 
data into. This technique was first used by Genotype-Tissue Expression (GTEx) Consortium to 
visualise gene expression variability among several tissues across individuals (Melé et al., 2015). 
In Figure 4.4 MDS plot of the BLUEPRINT (L. Chen et al., 2016) dataset is shown. Dataset 
contains three cell types and all three of them are clustered distinctly. There are no outliers to be 
analyzed further, and we consider data resulting in this kind of plot as high quality. However, in 
Figure 4.5 it can be clearly seen that samples marked with circles are located very far away form 
their respective clusters. These samples are considered as outliers and removed from dataset. 
 
Figure 4.4. MDS plot example from BLUEPRINT dataset (no outliers) 
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As expected, the same samples appear to be outliers (TWPID2140_F, TWPID10593_B, 
TWPID11605_B, TWPID12889_S and TWPID8405_S) in both MDS (Figure 4.5) and PCA 
(Figure 4.3) analysis of TwinsUK dataset. This scenario gives additional confidence to eliminate 
these outlier samples from the dataset.  
To get a wider overview about variance between datasets we merged the several datasets and 
plotted the MDS output after decreasing the number of dimensions to two. These kinds of plots 
help us to understand the main contributing factors of the variance into the datasets. In order to 
 
Figure 4.5. MDS plot example from TwinsUK dataset. Samples TWPID2140_F, 
TWPID10593_B, TWPID11605_B, TWPID12889_S and TWPID8405_S are outliers. 
 
 
Figure 4.6. MDS plot of the 5278 distinct samples from seven datasets. Contains. Cell type 
and tissue specific clusters are clearly explaining most of the variance between samples. 
Clusters of Monocytes and T-cells are divided into two subclusters, showing additional 
variance depending on differences between studies’ datasets. 
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make the plot interpretable we only use samples with the “naive” condition (without any stimuli) 
and do not use datasets with very large number of biological contexts (e.g. GTEx). This filtering 
operation enables to decrease the noise and see the samples clustered according to some biological 
property. For instance, Figure 4.6 is a visualisation of MDS analysis of 5278 samples from 7 
datasets. 12 tissues and cell types are clustered distinctly, explaining the source of the main 
variance between samples. However, monocytes and T-cells show extra variance in comparison 
to other cell type specific clusters. Each of these clusters are divided into two distinct subclusters, 
explaining variance derived from differences between datasets.  
4.3. Sex-specific Gene Expression Analysis 
In addition to outlier samples, other common data quality issues are sample swaps (samples 
between two study participants have accidentally been swapped and mislabeled) and cross-
contamination between samples (RNA sample from individual A has been contaminated with 
RNA from individual B). It is not possible to spot the sample swaps or cross contamination of 
samples with PCA and MDS analyses, if affected samples are the same kind (same condition and 
cell type). One strategy to detect this type of data quality issues is to focus on genes that are 
exclusively expressed by one sex. ‘t Hoen et al. (’t Hoen et al., 2013) proposed to plot the 
expression of genes from the Y chromosome against the expression of the XIST gene which is 
only expressed in females. 
We generate a scatter plot with the XIST gene (ENSG00000229807 - found only in females) 
expression in horizontal axis and the Y chromosome gene expression (found only in males) in 
vertical axis, and set the color of each sample according to its donor’s sex. Plot from the 
GEUVADIS study (Lappalainen et al., 2013) is a good example of non-contaminated, correctly 
labeled lymphoblastoid samples (Figure 4.7). In this case, all of the male samples express genes 
from the Y chromosome and no XIST gene, whereas female samples express XIST gene but not 
the genes from the Y chromosome. The perfect separation between male and female samples also 
demonstrate how this analysis can be used to impute sex for RNA-seq samples if this data is not 
present in the original dataset. When there is cross-contamination between samples, the sex-
specific gene expression plot looks like the one from the BLUEPRINT (L. Chen et al., 2016) study 
(Figure 4.7). The blue dots (male samples) marked with circles expressed XIST gene which should 
only be expressed in females. Conversely, red dots (female samples) marked with circles also 
expressed genes from the Y chromosome which should only be present in males. This suggests 
that the two female samples (S003Q3B1_mRNA and S003Q3B1_RNA) have been cross-
contaminated by RNA from one or more male samples and the male samples (S003P5B1_mRNA 
and S003P5B1_RNA) have been cross-contaminated by RNA from one or more female samples 
(expressing the XIST gene). This could be caused by pipetting error while the samples were being 
processed in the lab. Consequently, these samples should be excluded from further analysis. 
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Sex-specific gene expression analysis is only effective if the metadata of dataset has sex 
information and the sample swap or contamination happened between samples belonging to donors 
with different sexes (e.g. male and female). 
4.4. Sequence-genotype Matching (MBV analysis) 
Another possibility to detect sample swaps is to directly compare the sample genotypes in VCF 
format to the genotype information that is present in the RNA-seq reads. MBV (Match BAM to 
VCF) is a method to detect mislabeling and technical bias in datasets that contain both genotype 
and sequencing (e.g. RNA-seq) data (Fort et al., 2017). This tool takes an aligned RNA-seq file 
(sample being tested) and a VCF file (Danecek et al., 2011) containing genotypic information of 
multiple samples as input and filters out undercovered variants according to provided parameter 
value. The variants with enough coverage are divided into two groups as homozygous and 
heterozygous sites. Finally, the proportion of consistent reads between the tested sample and each 
genotype sample in VCF file are measured for each group as shown in Formula 4.1. 
The MBV tool creates one output file per each sample in the dataset. All plots shown in Figure 4.8 
are generated from the MBV analysis output of Schwartzentruber et al. (Schwartzentruber et al., 
2018) dataset. Each dot on the plot represents one genotype sample in the VCF file and each plot 
 
Figure 4.7. Sex-specific gene expression plots of GEUVADIS (on the left cide, not contaminated) and 
BLUEPRINT (on the right side, contaminated) datasets 
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generated according to analysis of one RNA-seq file (sample being tested). Colors of dots indicate 
if the genotype sample is a match to a tested sample. Hence, a green dot on each plot representing 
the best match genotype sample, and other genotype samples are red. X axis represents consistency 
of the heterozygous sites calculated with Formula 4.1-5. Y axis represents consistency of 
homozygous sites calculated with Formula 4.1-4. For example, the plot in Figure 4.8a is a good 
example of a non-contaminated, correctly labeled sample. The RNA-seq sample SAMEA3234534 
is tested (consistency of both homozygous and heterozygous sites are calculated, Formula 4.1) 
against all of the genotype samples in the VCF file and only one genotype sample (HPSI0513i-
oarz_22) is found to have highly consistent matching sites to the tested sample. In this example, 
more than 97% of homozygous sites in the tested sample (SAMEA3234534) are also homozygous 
in HPSI0513i-oarz_22 genotype sample. Heterozygous sites also show same level of consistency 
(>97%) between tested sample (SAMEA3234534) and matched genotype sample (HPSI0513i-
oarz_22). Yet, consistency between the tested sample and other genotype samples in the VCF file 
are relatively low (consistency of heterozygous sites < 50%, consistency of homozygous sites < 
80%). Therefore, it can be concluded that the tested sample has only one genotype match in the 
VCF file and the sample is not cross-contaminated with genetic material of other samples.  
There are at least three possible conflicts between RNA-seq data and genotype data. Firstly, the 
genotypic data corresponding to the tested sample might not be present in the VCF file (Figure 
4.8b). This technical issue sometimes happens when genotypic data (samples in VCF file) of 
needed samples are extracted from a larger VCF file. It should be analysed further and fixed if 
possible. If not possible to fix, the sample missing genotypic data should be eliminated from the 
dataset. Secondly, the MBV tool is good for detecting cross-contamination between samples 
(Figure 4.8c). The tested sample is fully matched with one genotype sample but also partially 
matched with some other genotype. It usually indicates possible cross-contamination in the 
laboratory. Both of these potentially contaminated samples should be analysed in order to decide 
if to eliminate one or both of the samples from the dataset. Finally, the MBV output plot can look 
like as Figure 4.8d. In the top right corner we see only red dot instead of green. That is because 
the green dot is overwritten and located under the red one, which means that the tested sample is 
perfectly matched with more than one genotype in the VCF file. This indicates that there are 
 
Formula 4.1. Calculation method of consistent reads’ proportions grouped by site type (homozygous 
and heterozygous groups). Summarised according to supplementary material of (Fort et al., 2017) study. 
 
42 
duplicate samples in the dataset. For QTL analysis one of these duplicate samples usually needs 
to be excluded, because they cannot be considered as independent samples. 
Looking through all of the plots manually can be misleading, because it is easy to miss two 
overlapping samples on a plot. Instead, we analysed the distance between two best matching 
samples to detect potential contaminated and duplicated samples. For that reason, we generate a 
table containing all tested samples (sample_id), best matching genotype to the tested sample 
(mbv_gentotype_id), heterozygous and homozygous consistent fractions of the best match 
 
Figure 4.8. Examples of sequence-genotype matching analysis output plots from Schwartzentuber et al. (2018) 
dataset. X axis represents consistency of heterozygous sites (Formula 4.1-5). Y axis represents consistency of 
homozygous sites (Formula 4.1-4). a) Non-contaminated sample (SAMEA3234534) matches only one genotype 
(HPSI0513i-oarz_22) in the VCF file. b) The tested sample (SAMEA3476959) did not match to any genotype in 
the VCF file. c) Tested sample (SAMEA3864997) fully matches to one genotype (HPSI0613i-qony_1), but also 
partially matches another genotype (HPSI0214i-pelm_3) in the VCF file. d) Tested sample (SAMEA3234610) 
fully matches two genotypes (HPSI1213i-foqj_2 and HPSI0913i-ffdl_1) in the VCF file. 
 
Table 4.1. Example of minimum distance between best matching samples from BLUEPRINT study 
sample_id mbv_genotype_id het_consistent_frac hom_consistent_frac het_min_dist hom_min_dist dist 
S003Q3B1_mRNA S003Q3 0.989 0.688 0.173 0.09 0.196 
S003Q3B1_RNA S003Q3 0.99 0.735 0.223 0.108 0.248 
S003P5B1_mRNA S003P5 0.99 0.775 0.347 0.142 0.374 
S003P5B1_RNA S003P5 0.991 0.835 0.414 0.169 0.447 
S0026AB7 S0026A 0.996 0.89 0.494 0.231 0.545 
S007PQB5 S007PQ 0.995 0.909 0.495 0.23 0.546 
S0041CB7 S0041C 0.994 0.898 0.5 0.22 0.547 
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(het_consistent_frac and hom_consistent_frac), heterozygous and homozygous minimum distance 
to the second best genotype match to tested sample (het_min_dist and hom_min_dist), and overall 
distance from the best match to the second best match (dist) (Table 4.1). Table 4.1 represents the 
first 7 rows of a sequence-genotype matching analysis output table, ascendingly ordered by 
minimum distance between the best genotype match and the second best genotype match (dist) to 
the tested sample. These samples are potentially contaminated samples and need further analysis. 
To visualise the measurement of minimum distance between the best two matches, scatter plots of 
first (S003Q3B1_mRNA) and sixth (S007PQB5) samples in the table are shown in Figure 4.9. 
The tested sample S003Q3B1_mRNA in Figure 4.9 is an obvious contamination and should be 
eliminated from the dataset. As expected this sample from the BLUEPRINT (L. Chen et al., 2016) 
study appeared to be contaminated also in sex-specific gene expression analysis (Figure 4.7). 
However, the sample S007PQB5 does not seem to be a contaminated one, because the second best 
genotype match (S001C2) is located close to the cluster of unmatched genotypes. This case is open 
to interpretation of the bioinformatician and we decided to keep this sample. 
5. QTL Mapping Pipeline 
Computing association summary statistics with all required technical features (portability, 
scalability, reproducibility etc.) is the main goal of the QTL mapping pipeline. After quality control 
steps are performed and samples with poor quality are eliminated, the phenotype count matrix 
should be normalised according to the quantification method. The normalised phenotype matrix is 
considered ready for QTL mapping. We developed a pipeline which takes phenotype count matrix 
 
Figure 4.9. Plot of the two potentially contaminated samples’ sequence-genotype matching analysis. 
BLUEPRINT (L. Chen et al., 2016) study. Sample S003Q3B1_mRNA is fully matched to S003Q3 
genotype and partially matched to S003P5 genotype. Distance between the two best genotype 
matches is 0.196. Sample S007PQB5 is fully matched to S007PQ genotype and, the second best 
genotype match is S001C2. Distance between the two best matches is 0.546 
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(the output of the quantification pipeline, quality controlled, normalised), metadata files and 
genotype information as input to uniformly map a wide range of molecular QTLs. The pipeline is 
based on the widely used QTLtools software package (Delaneau et al., 2017) and is freely available 
for download from GitHub34.  
5.1. Description of QTL Mapping Process 
QTL mapping is the process of finding statistically significant associations between phenotypes 
and genetic variants located nearby (within a specific window around phenotype, a.k.a cis 
window), which is usually found using linear regressions. The process requires a large number of 
association tests to find all potential phenotype-variant associations in a cis window and produces 
p-values for each performed test. Because of the high number of existing phenotypes and the 
number of tests to be performed, accounting for multiple testing is essential to assess the 
significance of discovered associations. QTLtools (Delaneau et al., 2017) uses a fast and efficient 
permutation algorithm where the null distribution of association for phenotype is modeled based 
on the beta distribution (Ongen, Buil, Brown, Dermitzakis, & Delaneau, 2016). This enables to 
accurately estimate adjusted p-values in short running times.  
QTLtools provides two options to run the QTL mapping in cis window, namely nominal run and 
permutation run. The nominal run calculates only nominal p-values of the associations, given the 
null hypothesis of not having any association between a phenotype and variant. Permutation run, 
on the other hand, performs a permutation based analysis in order to adjust nominal p-values 
according to a fitted beta distribution from thousands of random permutations of the genotype data. 
Permutation run accounts for the number of genetic variants tested in the cis window and allows 
us to identify phenotypes that have at least one statistically significant QTL at a pre-determined 
false discovery rate. 
5.2. Pipeline Overview 
To develop the QTL mapping pipeline, we adopted the development style and some resources of 
the nf-core framework (Ewels et al., 2019), as we did in quantification pipeline development. Nf-
core initiated the idea of having bioinformatics pipelines in one unified pool. Nf-core pipelines are 
containerized, easy-to-use, open-source, tested and continuously maintained by the contributor 
developers. They also provide pipeline development tools35 to encourage developers to contribute 
new pipelines and widen the community. We developed the QTL mapping pipeline (qtlmap) to be 
added to nf-core set of pipelines. The overview of the pipeline and brief explanation of each step 
is described in Figure 5.1.  
                                                 
34
 https://github.com/kerimoff/qtlmap 
35
 https://github.com/nf-core/tools 
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The pipeline starts execution with checking if all the mandatory inputs are provided (not shown in 
the Figure 5.1). Then, if the all provided inputs are valid, information (coordinates, alleles, etc.) 
about all the variants in the provided VCF file are extracted. Genotypic variant information 
together with sample metadata files and the phenotype count matrix are passed into the custom 
script group_by_qtlgoup.R36 in order to filter out the problematic phenotypes and group samples 
by QTL group. After asserting that all needed columns are available in datasets, we find variants 
                                                 
36
 https://github.com/kerimoff/qtlmap/blob/master/bin/group_by_qtlgroup.R 
 
Figure 5.1. High level representation of qtlmap pipeline. Shapes with yellow background are the 
steps (processes) and shapes with white background symbolize data objects (files). 
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(from variant information) overlapping with cis window of phenotypic features (from phenotype 
metadata) (Figure 5.2). We introduced a filtering parameter mincisvariant37 (with a default value 
of 5) to avoid processing phenotypes with very few variants in the cis window, because QTLtools 
simply stop working (e.g. raises error) if there are no overlapping variants in cis window of the 
phenotype. Hence, by default, if the phenotype has less than 5 variants in the cis window, this 
phenotype is filtered out from the phenotype count matrix. After removing phenotypes with very 
few variants (less than mincisvariant) from the phenotype matrix, we divide it into submatrices 
according to qtl_group information provided in the sample metadata file. QTL groups usually 
represent different tissues, cell types or other biological contexts (e.g. experimental stimulation) 
present in the datasets. These submatrices are processed individually and in parallel through the 
next steps of the pipeline. 
Genotypic information of samples represented in each QTL group are also extracted from the VCF 
file, forming VCF files containing only samples belonging to each QTL group. First output of the 
pipeline is the variant information extracted from each of these QTL group specific VCF files. 
QTLtools uses PCA covariates in the QTL mapping process. PCA of the phenotype matrix is used 
in order to remove technical variance between samples and increases the power of detecting 
significant associations. On the other hand, PCA of genotypic information is used to take origin of 
the genotypic information (e.g. population structure) into account in the QTL mapping process. 
We used six principal components of the phenotype matrix and three principal components of 
genotypic data as covariates in QTL mapping process. In order to map the QTLs, PCA covariates 
matrix together with QTL group specific VCF file and phenotype matrix are provided as inputs to 
the QTLtools. QTLtools process these inputs in parallel according to specified number of 
batches38. Ultimately, individually calculated outputs of batches are merged into a single summary 
statistics file for each QTL group. 
                                                 
37
 https://github.com/kerimoff/qtlmap/blob/master/docs/usage.md#--mincisvariant 
38
 https://github.com/kerimoff/qtlmap/blob/master/docs/usage.md#--n_batches 
 
Figure 5.2. Finding genomic variants overlapping with the cis window of the phenotype. In example, 
cis distance is 1 million sequence bases and the length of cis window is 2 million bases. Genomic 
variants which overlapped with the cis window of the phenotype are shown in green. Genomic 
variants remaining out of the cis window represented in red color. The phenotype has 9 overlapping 
variants in its cis window, which is more than 5 (default value of mincisvariant parameter). Hence 
this phenotype will be processed in QTL mapping procedure. 
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5.3. Pipeline Implementation Details 
There are a number of tools available to map QTLs such as QTLtools and MatrixEQTL (Delaneau 
et al., 2017; Shabalin, 2012). Moreover, the MOLGENIS (van der Velde et al. 2019) project 
provides a set of scripts and step-by-step guidelines to use them in order to map QTLs39. Another 
reason why we decided to use QTLtools is that it provides options to facilitate parallelisation on 
compute cluster for both cis mapping running options (nominal40 and permutation41 runs). 
Especially in permutation run this parallelisation feature increases efficacy of the analysis, because 
it does multiple permutation tests to adjust p-values which is computationally intensive. For 
instance, by default we perform ten thousand (10,000) permutations in one megabase (1 Mb) cis 
distance to obtain accurate adjusted p-values. Moreover, we also use PCA42 module of QTLtools 
to calculate covariates. Besides the preprocessing steps needed for QTL mapping, our pipeline is 
smoothly managing these multiple parallel tasks by processing them in specified number of 
batches (one parallel node per batch) and finally merging them into a single output file. 
Hardware requirements of each step of the pipeline is configured in a base configuration file43 and 
the set values are the result of personal experience of researchers involved in the project. The 
current version of the pipeline can only perform the cis-QTL mapping, however, we are working 
to add trans-QTL mapping option also in the future. 
5.3.1. Containerisation and Conda support 
To provide maximum level of dependency isolation, Nextflow provides very good integration with 
both Conda and containerisation (e.g. Docker and Singularity). We analysed all the dependencies 
for this pipeline and created a Conda software recipe (Figure 2.1). User can create a “Conda 
environment” with this recipe in an execution environment (e.g. HPC or PC) and run the pipeline 
without worrying about software dependencies. Nf-core provided a nice template to build a 
software container using a Conda environment recipe. Specifically they provide a base image 
which contains the operating system and Conda installed. I have built the needed containers using 
Dockerfile and Singularity file which are also provided by nf-core and pushed them to Docker Hub 
and Singularity-Hub, respectively. The address of the Docker container has been entered into 
pipeline settings, hence, users only need to specify if they want to run the pipeline with the 
container (Docker or Singularity) and the pipeline will automatically download the container from 
Docker Hub and use it. Since Singularity supports direct usage of Docker containers, I have 
included only the address of the Docker container into the pipeline. 
                                                 
39
 https://github.com/molgenis/systemsgenetics/wiki/eQTL-mapping-analysis-cookbook-for-RNA-seq-data 
40
 https://qtltools.github.io/qtltools/pages/mode_cis_nominal.html 
41
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43
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We processed more than 40 QTL groups from more than 15 studies (Appendix 1) with this 
pipeline. To verify that the results make sense, we plotted the number of eQTLs detected in each 
biological context (qtl_group) against the sample size of that context and discovered more than 
9000 eGenes (genes which have at least one significant SNP in the cis window) (Figure 5.3). As 
expected, we found a linear relationship between the number of eGenes and the sample size. 
5.4. Pipeline Input and Output Description 
Although the pipeline is developed to be user-friendly and ready-to-use, there is a data preparation 
step which requires a little effort to ensure having mandatory format and content of the input files.  
5.4.1. Input Preparation 
We decided to use simple text files (e.g. tab separated value, TSV) as the main format of tabular 
input files for our pipeline. Pipeline requires 4 input files to map the QTLs.  
1. Phenotype count matrix of the quantitative traits: tab separated file containing normalised 
phenotype counts (e.g. gene expression matrix). Columns and rows represent samples and 
phenotypes, respectively.  
2. Phenotype metadata: tab separated file containing metadata of phenotypes appearing in 
count matrix as rows. This table should have at least the following information: 
phenotype_id (this column links the metadata to count matrix), chromosome, 
phenotype_pos, strand. The chromosome and position of each phenotype is used to define 
the genomic region around the phenotype that is used for QTL mapping (cis window). 
 
Figure 5.3. Correlation of eGenes with sample size within each QTL group. Imputed genotypes: 1000 Genomes 
Phase 3*; Genotype filtering: MAF > 0.01 & R^2 > 0.4; Covariates: 6 expression PCs + 3 genotype PCs; Cis 
window: +/- 1Mb from gene center; FDR correction: 10,000 permutation + Benjamini-Hochberg FDR < 0.05. 
Figure prepared by Kaur Alasoo for presentation purposes of quarterly results of the project. 
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3. Sample metadata: tab separated file containing metadata of samples appearing in count 
matrix as columns. This table should have at least the following information: sample_id 
(this column links the metadata to the count matrix), genotype_id, qtl_group 
4. Variant Call Format (VCF) file: genotype information of samples to map the QTLs to. 
Input files are coupled to each other through specific parameters (Figure 5.4). Phenotype count 
matrix is the main data table for the pipeline. Pipeline manipulates phenotype count matrix 
according to metadata files and maps it to VCF file. Although, it is important to have the mandatory 
columns in each metadata file, preparing them is straightforward. The count matrix dataset will be 
grouped into subsets according to qtl_group information in the sample metadata file.  
For instance, TwinUK dataset contains 1364 samples originated from 4 biological contexts (in this 
case cell-type and tissues), namely LCL, skin, fat and blood (Table 1.2 and Appendix 1). Although 
the phenotype count matrix of this dataset will contain phenotype expression levels of 1364 
samples, this matrix will be divided into 4 distinct matrices according to qtl_group value in the 
sample metadata file of the dataset. These 4 matrices will be processed individually in order to 
map the QTLs.  
 
Figure 5.4. Description of relations between required input files for QTL mapping with pipeline. Count 
matrix has a phenotype_id column which corresponds to column with the same name in phenotype metadata 
file. Other column names of count matrix (sample_ABC and sample_DEF) corresponds to the values of 
sample_id column in sample metadata file. Values of the genotype_id column in sample metadata file 
corresponds to genotype_ids in VCF file. Count matrix is divided into submatrices (in this case, each of two 
submatrices contains only one sample) according to values of the qtl_group column in sample metadata file 
and processed individually. chromosome, phenoype_pos and strand information of each phenotype (in 
phenotype metadata file) is used to define the cis window that is used for QTL mapping. 
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Finally, the genotype ids present in the VCF file should correspond to values of genotype_id 
column in sample metadata file. For a complete set of available parameters see the pipeline 
documentation44.  
5.4.2. Description and Interpretation of Pipeline Output 
The main final output of the QTL mapping pipeline is a sorted and indexed text file of summary 
statistics. This file summarises the associations between phenotypes and genetic variants. The 
output of the nominal run contains the nominal phenotype information (id, chromosome, strand, 
start and end positions), genetic variant information (id, chromosome, start and end positions), test 
information (number of variants tested per phenotype, distance between the phenotype and 
associated variant) and association details (nominal p-value, effect size and a binary flag showing 
if the associated variant has the lowest p-value a.k.a. lead variant)45.  
6. Conclusions 
In the context of the eQTL Catalog project, we implemented all the necessary steps to uniformly 
generate QTL summary statistics from RNA-seq and genotype data from multiple studies. The 
whole process can be summarised as three distinct steps: 
1. Quantification of the required phenotypes (gene expression, transcript usage, exon 
expression and alternative splicing usage) from raw RNA-seq data (including pre-
quantification quality control steps) with the quantification pipeline. 
2. Post-quantification manual quality control (PCA, MDS, sex-specific gene expression and 
sequence-genotype matching analyses) and elimination of samples with poor quality. 
3. QTL mapping pipeline input preparation and running. 
In the first step we added new phenotype quantification methods (transcript usage, exon 
expressions and alternative splicing usage) to an existing RNA-seq pipeline developed by the nf-
core framework. In order to isolate software dependencies, it fully supports package managers like 
Conda and container technologies such as Docker and Singularity. The output of the pipeline is a 
phenotype count matrix which represents expression levels of quantitative traits in the RNA-seq 
data. 
The second step is detection and elimination of mislabeled, contaminated and poor quality 
samples, in order to increase the quality and precision of summary statistics. To detect outlier 
samples in the dataset we apply PCA and MDS analyses. For identification of mislabeling and 
contamination issues we analyse the sex-specific gene expression and the sequence-genotype 
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matching levels of samples. If the reason of the issue is not evident or correctable, we eliminate 
the concerned samples from the dataset. 
After post-quantification quality control measures, the phenotype count matrix together with 
phenotype metadata, sample metadata and genotype (VCF) files are given into the QTL mapping 
pipeline in order to produce summary statistics. This pipeline is also designed to be containerised, 
easy-to-use, parallelly executable, scalable, open-source and ready-to-use, as all other pipelines in 
the nf-core framework. We implemented it to ease the QTL mapping analysis process for users 
and uniformly process context specific datasets of multiple studies. Although the pipeline is much 
simpler to use than existing QTL mapping tools, some data preparation effort is still needed. 
Currently, the pipeline performs only cis QTL mapping, but we are planning to add trans-QTL 
mapping in the near future.  
The next step in development of the pipeline is consulting with the nf-core team and decide if this 
pipeline is suitable to be added to nf-core set of reference pipelines. Continuous integration and 
HTML reports are also features to be added to the pipeline. Additionally, we are looking for a 
suitable method to merge similar biological contexts across different studies (e.g. blood tissue 
samples from two different studies) and process them as a unified QTL group. Successful 
implementation of this approach can substantially increase the statistical power of the QTL 
mapping, facilitating the discovery of weaker trans-eQTLs, for which most individual studies are 
currently underpowered. 
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8. Appendices 
1. Full list of studies processed in a context of eQTL Catalog project (List is prepared by main researcher of the project Kaur 
Alasoo for documentation purposes). All datasets also have a “naive” stimulation, where there is no any stimulation applied. 
For instance, dataset of Alasoo_2018 study has 3 stimultions in addition to naive, hence it has 4 qtl_groups. 
Study name 
Number of 
donors 
Number of 
samples 
Experiment 
type 
Cell types or 
tissues 
Stimulations 
Number of 
qtl_group’s 
Publication DOI 
CEDAR 322 2388 microarray 
T-cell, 
transverse_colon, 
monocyte, 
neutrophil, platelet, 
rectum, B-cell, 
ileum 
 8 http://dx.doi.org/10.1038/s41467-018-04365-8  
Fairfax_2012 282 282 microarray B-cell  1 http://dx.doi.org/10.1038/ng.2205  
Fairfax_2014 424 1372 microarray monocyte 
IFN24, LPS2, 
LPS24 
4 http://dx.doi.org/10.1126/science.1246949  
Kasela_2017 297 553 microarray T-cell  1 http://dx.doi.org/10.1371/journal.pgen.1006643  
Naranbhai_2015 93 93 microarray neutrophil  1 http://dx.doi.org/10.1038/ncomms8545  
Raj_2014 515 984 microarray T-cell, monocyte  2 http://dx.doi.org/10.1126/science.1249547  
Alasoo_2018 84 336 RNA-seq macrophage 
IFNg, 
Salmonella, 
IFNg+Salmonella 
4 http://dx.doi.org/10.1038/s41588-018-0046-7  
BLUEPRINT 197 554 RNA-seq 
monocyte, 
neutrophil, T-cell 
 3 https://doi.org/10.1016/j.cell.2016.10.026  
62 
GENCORD 195 560 RNA-seq 
LCL, fibroblast, T-
cell 
 3 https://doi.org/10.7554/eLife.00523  
GEUVADIS 445 445 RNA-seq LCL  1 https://doi.org/10.1038/nature12531  
HipSci 322 322 RNA-seq iPSC  1 https://doi.org/10.1038/nature22403  
Nedelec_2016 168 493 RNA-seq macrophage 
Listeria, 
Salmonella 
3 http://dx.doi.org/10.1016/j.cell.2016.09.025  
Quach_2016 200 969 RNA-seq monocyte 
LPS, 
Pam3CSK4, 
R848, IAV 
5 http://dx.doi.org/10.1016/j.cell.2016.09.024  
Schwartzentruber_2018 98 98 RNA-seq sensory_neuron  1 http://dx.doi.org/10.1038/s41588-017-0005-8  
TwinsUK 433 1364 RNA-seq 
fat, LCL, skin, 
blood 
 4 http://dx.doi.org/10.1038/ng.3162  
van_de_Bunt_2015 117 117 RNA-seq pancreatic_islet  1 https://doi.org/10.1371/journal.pgen.1005694  
Ye_2018 261 573 RNA-seq dendritic_cell IFN, FLU 3 http://dx.doi.org/10.1101/gr.240390.118  
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